Skip to main content

Maria Mar Hernandez Guillamon

Senior Researcher, Neurovascular Research Lab, VHIR.

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Maria Mar Hernandez Guillamon

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Senior Researcher, Neurovascular Research Lab, VHIR.

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.

Projects

Estada al Dpt. de Patologia del New York University Medical School

IP: Joan Montaner Villalonga
Collaborators: Maria Mar Hernandez Guillamon
Funding agency: Instituto de Salud Carlos III
Funding: 1800
Reference: ESTSB-2010-01
Duration: 11/05/2010 - 14/07/2010

Mecanismos patogénicos de daño endotelial y neuronal (in vitro) producido por el suero de pacientes con ictus agudo y relación con los procesos oxidativos (in vivo) tras la isquemia cerebral

IP: -
Collaborators: Maria Mar Hernandez Guillamon
Funding agency: Instituto de Salud Carlos III
Funding: 113740
Reference: PI10/01605
Duration: 01/01/2011 - 31/12/2014

Beneficio de la Simvastatina en el tratamiento trombólico combinado del ictus en modelos de isquemia cerebral en rata

IP: Maria Mar Hernandez Guillamon
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 126687
Reference: PI080481
Duration: 01/01/2009 - 31/12/2011

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: Raquel Arias Gonzalez, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 46800
Reference: 2009 SGR 432
Duration: 01/01/2010 - 30/04/2014

Related news

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Mercè Roca Lòpez

Mercè Roca Lòpez

Administration and Management
Read more
Remedios Rios Barrera

Remedios Rios Barrera

Senior researcher
Cardiovascular Diseases
Read more
Yassin Belahnech Pujol

Yassin Belahnech Pujol

Main researcher
Cardiovascular Diseases
Read more
Hakima Ouaarab Essadek

Hakima Ouaarab Essadek

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.